241 related articles for article (PubMed ID: 32132070)
1. Mucinous Adenocarcinoma as a High-risk Factor in Stage II Colorectal Cancer: A Propensity Score-matched Study from Japan.
Wang L; Hirano Y; Heng G; Ishii T; Kondo H; Hara K; Obara N; Asari M; Kato T; Yamaguchi S
Anticancer Res; 2020 Mar; 40(3):1651-1659. PubMed ID: 32132070
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
3. Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study.
Wu X; Lin H; Li S
BMC Gastroenterol; 2019 Oct; 19(1):164. PubMed ID: 31601167
[TBL] [Abstract][Full Text] [Related]
4. The association of mucinous histology with clinicopathological characteristics and long-term oncological outcome in patients with colorectal cancer.
Tümay V; Guner OS
Ann Ital Chir; 2020; 91():639-648. PubMed ID: 32990276
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of Histologic Type in Curatively Resected Stage IV Colorectal Cancer: A Japanese Multicenter Retrospective Study.
Shibata J; Kawai K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Sugihara K; Watanabe T
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S621-9. PubMed ID: 26350364
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy.
Lee DW; Han SW; Lee HJ; Rhee YY; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
Br J Cancer; 2013 May; 108(10):1978-84. PubMed ID: 23652310
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched study.
Yan C; Yang H; Chen L; Liu R; Shang W; Yuan W; Yang F; Sun Q; Xia L
BMC Cancer; 2021 Dec; 21(1):1286. PubMed ID: 34852768
[TBL] [Abstract][Full Text] [Related]
8. Inverse effect of mucinous component on survival in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Yamamoto G; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(7):851-7. PubMed ID: 25111953
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Relevance of Mucinous Subtype in a Population-based Propensity Score Analysis of 40,083 Rectal Cancer Patients.
Tarantino I; Hüttner FJ; Warschkow R; Schmied BM; Diener MK; Ulrich A
Ann Surg Oncol; 2016 May; 23(5):1576-86. PubMed ID: 26714956
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the mucin component in stage III rectal carcinoma patients.
Wang M; Zhang YC; Yang XY; Wang ZQ
Asian Pac J Cancer Prev; 2014; 15(19):8101-5. PubMed ID: 25338991
[TBL] [Abstract][Full Text] [Related]
11. Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment.
Ott C; Gerken M; Hirsch D; Fest P; Fichtner-Feigl S; Munker S; Schnoy E; Stroszczynski C; Vogelhuber M; Herr W; Evert M; Reng M; Schlitt HJ; Klinkhammer-Schalke M; Teufel A
Digestion; 2018; 98(3):143-152. PubMed ID: 29870979
[TBL] [Abstract][Full Text] [Related]
12. Using nomograms to predict prognostic factors in young colorectal mucinous and signet-ring cell adenocarcinoma patients.
Wang B; Zeng J; Liu Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 30692229
[TBL] [Abstract][Full Text] [Related]
13. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
[TBL] [Abstract][Full Text] [Related]
15. Impact of Lymphovascular Invasion in Patients With Stage II Colorectal Cancer: A Propensity Score-matched Study.
Kataoka M; Hirano Y; Ishii T; Kondo H; Asari M; Ishikawa S; Kataoka A; Fujii T; Shimamura S; Yamaguchi S
In Vivo; 2021; 35(1):525-531. PubMed ID: 33402505
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features of colorectal mucinous adenocarcinoma].
Song W; He YL; Cai SR; Zhang CH; Chen CQ; Peng JJ; Zhan WH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):487-90. PubMed ID: 19742341
[TBL] [Abstract][Full Text] [Related]
17. Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study.
Viganò L; Russolillo N; Ferrero A; De Rosa G; Ferreri E; Forchino F; Sperti E; Capussotti L
Ann Surg; 2014 Nov; 260(5):878-84; discussion 884-5. PubMed ID: 25379857
[TBL] [Abstract][Full Text] [Related]
18. Does signet ring cell carcinoma component signify worse outcomes for patients with colorectal cancer?
Wang L; Hirano Y; Heng G; Ishii T; Kondo H; Hara K; Obara N; Asari M; Kato T; Yamaguchi S
Asian J Surg; 2021 Jan; 44(1):105-110. PubMed ID: 32295719
[TBL] [Abstract][Full Text] [Related]
19. [Predictive value of preoperative detection of CEA and CA199 for prognosis in patients with stage II-III colorectal cancer].
Chen L; Jiang B; Di J; Zhang C; Wang Z; Zhang N; Xing J; Cui M; Yang H; Yao Z; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):914-9. PubMed ID: 26404690
[TBL] [Abstract][Full Text] [Related]
20. KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX.
Lee DW; Kim KJ; Han SW; Lee HJ; Rhee YY; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
Ann Surg Oncol; 2015 Jan; 22(1):187-94. PubMed ID: 24889488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
